申请人:A Nattermann & CIE GmbH
公开号:US04873350A1
公开(公告)日:1989-10-10
The present invention relates to new diselenobis-benzoic acid amides of primary and secondary amines of the general formula (I): ##STR1## and processes for the treatment of diseases in humans caused by a cell injury.
本发明涉及一般式(I)的新二硒代苯甲酸酰胺,其中R1和R2分别代表一级和二级胺,并涉及用于治疗人类因细胞损伤引起的疾病的方法。